LOARGYS DIN 02568713
Health Canada record
| Active ingredient(s) | PEGZILARGINASE 5 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous; Subcutaneous |
| Schedule | PRESCRIPTION; SCHEDULE D |
| Class | Human |
| ATC | A16AB24 PEGZILARGINASE |
| Original market date | |
| Current status date | 29-May-2026 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 37628 | 2026-05-29 | New Drug Submission (NDS) |